Panretin Gel
NDC Package 59212-601-22

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Panretin (alitretinoin) gel is a medication used to treat skin sores in patients with a certain type of AIDS-related cancer (Kaposi's sarcoma). This formulation utilizes a gel delivery system. Marketed by Advanz Pharma (us) Corp., this product is identified by NDC 59212-601 and is authorized under FDA application NDA020886.

Identification & Billing

NDC Package Code
59212-601-22
Package Description
60 g in 1 TUBE
Product Code
59212-601
11-Digit Billing Format
59212060122
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
60 GM
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Panretin
Non-Proprietary Name
Alitretinoin
Substance Name
Alitretinoin
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
ALITRETINOIN 60 mg/60g
Pharmacologic Class
Usage Information
This medication is used to treat skin sores in patients with a certain type of AIDS-related cancer (Kaposi's sarcoma). Alitretinoin belongs to a class of medications called retinoids. It works by affecting the growth of skin cells. This medication should not be used when medications taken by mouth are needed to treat the Kaposi's sarcoma (for example, if you have had more than 10 new skin sores in the previous month, or if the disease affects the lungs or other organs).

Regulatory & Marketing

Labeler Name
Advanz Pharma (us) Corp.
Product Type
Human Prescription Drug
FDA Application #
NDA020886
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-10-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59212-601-22 identifies a specific commercial package of 60 g in 1 tube of Panretin, a human prescription drug labeled by Advanz Pharma (us) Corp.. This product is billed per "GM" gram and contains an estimated amount of 60 billable units per package. This gel is formulated for topical use and contains alitretinoin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advanz Pharma (us) Corp. on September 10, 2019. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat skin sores in patients with a certain type of AIDS-related cancer (Kaposi's sarcoma). Alitretinoin belongs to a class of medications called retinoids. It works by affecting the growth of skin cells. This medication should not be used when medications taken by mouth are needed to treat the Kaposi's sarcoma (for example, if you have had more than 10 new skin sores in the previous month, or if the disease affects the lungs or other organs).

How is this Advanz Pharma (us) Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59212060122. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59212-601-22
11-Digit CMS (5-4-2)
59212-0601-22

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.